Public Profile

Vectura

Vectura Group plc, headquartered in Great Britain, is a leading player in the pharmaceutical industry, specialising in the development of inhalation products and drug delivery solutions. Founded in 1997, Vectura has achieved significant milestones, including partnerships with major pharmaceutical companies to enhance respiratory therapies. The company focuses on innovative formulations and device technologies, particularly for asthma and chronic obstructive pulmonary disease (COPD). Vectura's unique approach combines expertise in inhalation science with advanced manufacturing capabilities, positioning it as a trusted partner in the respiratory market. With a strong presence in Europe and North America, Vectura has established itself as a key contributor to improving patient outcomes through its core products and services. Its commitment to research and development continues to drive its success and market leadership in the inhalation therapeutics sector.

DitchCarbon Score

How does Vectura's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

22

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

22

Industry Benchmark

Vectura's score of 22 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.

72%

Vectura's reported carbon emissions

In 2019, Vectura reported total carbon emissions of approximately 2,763,000 kg CO2e from Scope 1 and 1,172,000 kg CO2e from Scope 2, amounting to a combined total of about 3,935,000 kg CO2e. This marked a significant increase in emissions compared to previous years, with 2018 emissions at approximately 3,792,000 kg CO2e, 2017 at about 3,834,000 kg CO2e, and 2016 at around 1,628,000 kg CO2e. Vectura has not disclosed any specific reduction targets or initiatives as part of their climate commitments. The company has reported emissions data for Scope 1 and Scope 2 but has not provided information on Scope 3 emissions. As of now, Vectura's climate strategy appears to be in the early stages, with no formal climate pledges or science-based targets established. Overall, Vectura's emissions data highlights the need for a more robust approach to carbon management and sustainability in line with industry standards.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20142016201720182019
Scope 1
142,000
000,000
0,000,000
0,000,000
0,000,000
Scope 2
1,272,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 3
-
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Vectura's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Vectura is headquartered in GB, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Vectura is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Was this information valuable to you?

Similar Organizations

Consort Medical plc

GB
Health and social work services (85)
Updated 21 days ago

Cosmo Pharmaceuticals N.V.

IE
Chemicals nec
Updated 21 days ago

Hikma Pharmaceuticals

GB
Health and social work services (85)
Updated 1 day ago

Collegium Pharmaceutical, Inc.

US
Chemicals nec
Updated 24 days ago

MorphoSys

DE
Other business services (74)
Updated 28 days ago

Sopharma AD

BG
Chemicals nec
Updated 24 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers